Form D · Agriculture

Ascribe Bioscience Inc.

Ithaca, NY · CIK 0001882999

Offering snapshot reported Oct 15, 2025 · SEC filing

Reported sold
$15M
Offering amount: $15.3M
Investors reported
11
Form D · investor count
Minimum accepted
$5K
Reported outside-investor minimum
First sale
Oct 8, 2025
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 15, 2025Initial$15,019,027No comparison11SEC filing
Oct 7, 2024Initial$2,150,000No comparison5SEC filing
Aug 3, 2022Initial$3,184,996No comparison7SEC filing
Sep 15, 2021Initial$2,500,000No comparisonNot reportedSEC filing

Offering details

Securities
Equity, Option to acquire
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-560905

Source: Form D, filed Oct 15, 2025. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Alex Bondar Director
Jay Farmer Director, Executive
Fred Gruis Director
Frank Schroeder Director
Kyle Welborn Director

Issuer details

Industry: Agriculture (See others in industry)

Address:
95 Brown Road Suite 202
Ithaca, NY, 14850
Phone: 607-703-9083